semaglutide patient teaching STEP 1 : Treatment Effect in People with Obesity – My Endo Consult How Long Does It Take

What was happening: dormant follicles were waking up

Listed patents must relate to the drug substance, the drug product, or an approved method of use

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist because they mimic the GLP-1 hormone

Obviously, it is a limited publication type in its text, where more detailed information is not possible, but it expresses the most relevant data from current research both in preclinical trials and with well-referenced clinical trials

Your body is recalibrating: Hunger hormone signaling takes time to equilibrate at the new dose GI motility adjusts (often slower gastric emptying = more bloating/water early on) The glucagon component at higher doses can cause temporary mild water retention What looks like a plateau is often the new dose settling in